Ondansetron Base

Ondansetron blocks the actions of chemicals in the body that can trigger nausea and vomiting.

Ondansetron is used to prevent nausea and vomiting that may be caused by surgery, cancer chemotherapy, or radiation treatment.

Ondansetron may be used for purposes not listed in this medication guide.

Certificate of Analysis

  • Description

    A White to off-white Powder.

    Result

    An off White coloured powder.

  • Solution

    Freely soluble in acid solution & sparingly soluble in 0.1N HCI.

    Result

    Freely soluble in acid solution & sparingly soluble in 0.1N HCI.

  • Identification by IR

    The IR Spectrum of the sample should be in concordant with that of “ Ondansetron working standard.”

    Result

    Complies

  • Identification by HPLC

    The retention time of the sample should be in concordant with that of the Ondansetron working standard in “Assay by HPLC“ test.

    Result

    Complies

  • Water by KF

    Not more than 3.0 % w/w.

    Result

    1.7 % w/w.

  • Residue on ignition

    Not more than 0.1 % w/w.

    Result

    0.02 % w/w.

  • Chloride test

    Chloride test

    Result

    Below 0.02 %

  • Limits of Ondansetron related compound D

    Not more than 0.10 %

    Result

    Below LOQ

  • Related substances by HPLC
    Result

  • Individual Impurity

    Not more than 0.1 %

    Result

    0.04 %

  • Total impurities

    Not more than 0.5 %

    Result

    0.04%

  • Assay by HPLC (On anhydrous basis)

    98.0 % – 102.0 % w/w.

    Result

    99.8 % w/w.

Note: We are leading channel partner of much API manufacturer, supplier & exporters and Pharmaceutical raw material in Colombo, Chili, Ecuador and Globally.

Material Safety Data Sheet

  • Section 1 – Chemical Product

    Product Identifier

    Ondansetron Base

    MSDS Prepared By

    R&D Department

  • Section 2 – Composition / Information Of Ingredients

    Product Name

    Ondansetron Base

    Synonym

    0-Methyl-3-2) 2-methyl-imidazol-1-ylmethyl) -1,2,3,9-tetrahydro-carbazol-4-one

    Molecular Formula

    C18H19N3O

    Molecular Weight

    293.36

    CAS Number

    99614-02-5

  • Section 3 – HAZARDOUS IDENTIFICATION

    Emergency Overview

    Irritating to eyes, respiratory system and skin.

    Potential Health Effects

    Eyes

    Cause eye irritation.

    Skin

    Cause skin irritation. May be harmful, if absorbed through skin.

    Ingestion

    May cause irritation of the digestive tract. May be harmful if swallowed.

    Inhalation

    May cause respiratory tract irritation. May be harmful if inhaled.

    Chronic

    N/A

  • Section 4 – FIRST AID

    Skin Contact

    Wipe off excess material from skin then immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical attention immediately, Wash clothing and shoes thoroughly before reuse.

    Eye Contact

    Immediately flush eyes with plenty of water for at least 15 minutes lifting lower and upper eyelids occasionally. Get medical attention immediately.

    Inhalation

    Remove to fresh air. Get medical attention immediately.

    Ingestion

    If swallowed, INDUCE VOMITTING. Give large quantities of water. Never give anything by mouth to an unconscious person. Get medical attention immediately.

  • Section 5 – FIRE FIGHTING MEASURES

    General Information

    As in any fire, wear a self-contained breathing apparatus in pressure-demand, and full protective wear.

    Extinguishing Media

    Use water spray, dry chemical, carbon dioxide or chemical form.

  • Section 6 – ACCIDENT RELEASE MEASURES

    General Information

    Use proper personal protective equipment as indicated in Sction-8.

    Spills/Leaks

    Ventilate area of spill. Isolate hazard area. Keep away unnecessary and unprotected personnel from entering. Flush with water. Use wet mop or vacuum to pick up spilled product. Dispose the collected powder and washings as per local laws.

  • Section 7 – HANDLING AND STORAGE

    Handling

    Avoiding breathing powder, vapor, mist or gas. Avoid contact with skin and eyes.

    Storage

    Preserve in air tight containers protected from light.

  • Section 8 – EXPOSURE CONTROLS / PERSONAL PROTECTION

    Engineering Controls

    Facilities storing or utilizing this material should be equipped with an eye wash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.

    Personal Protective Equipment

    Skin

    Wear appropriate protective glove to prevent skin exposure.

    Eye Protection

    Wear appropriate protective eyeglasses or chemical safety googles as described by OSHA`s eye & face protective regulations.

    Clothing

    Wear appropriate protective clothing to prevent skin exposure.

    Respirators

    Follow the OSHA respirators regulations.

  • Section 9 – PHYSICAL AND CHEMICAL PROPERITIES

    Physical State

    Powder

    Color

    An off white to white crystalline Powder

    Odor

    N/A

    Viscosity

    N/A

    Auto-ignition Temperature

    N/A

    Flash Point

    N/A

    Explosion Limit, Lower

    N/A

    Decomposition Temperature

    N/A

    Solubility in Water

    N/A

    Freezing / Melting Point

    N/A

    Specific Gravity / Density

    N/A

    Vapour Density

    N/A

    Vapour Pressure

    N/A

    Assay

    98 % (+)

  • Section 10 – STABILITY AND REACTIVITY

    Chemical Stability

    Suitable at Room temperature in closed containers under normal storage and humidity condition.

    Conditions to avoid

    Incompatible materials

    Incompatible with Others

    Strong oxidizing agents.

    Hazardous decomposition products

    Hydrogen bromide, Nitrogen oxide, Carbon monoxide.

    Hazardous Polymerization

    Has not been reported.

  • Section 11 – TOXICOLOGICAL INFORMATION

    Oral Rat

    LD 50: 350 mg/kg

    General Information

    To the best of our knowledge the toxicological properties have not been thoroughly investigated. However, harmful if swallowed in large amount, causes irritation if it contacts with eyes.

  • Section 12 – ECOLOGICAL INFORMATION

    Data Not Available.

  • Section 13 – DISPOSAL CONSIDERATION

    Waste Disposal

    Whatever cannot be saved for recovery or recycling should be managed in an appropriate and approved waste disposal facility. Processing, use or contamination of this product may change the waste management options. Dispose off container and unused contents in accordance with federal and local requirements.

  • Section 14 – TRANSPORT INFORMATION

    General Information

    IATA Non-hazardous transport.

  • Section 15 – REGULATORY INFORMATION

    European / International Regulations

    Hazard Symbols

    Non-hazardous

    Risk Phrases

    Irritating to eyes, respiratory system and skin.

    Safety Phrases

    In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

  • Section 16 – OTHER INFORMATION

    Global Pharma provides information contained herein in good faith but makes no representation as to its comprehensives or accuracy. This document is intended only as a guide to the appropriate precautionary handling of the material by a properly trained person using this product.

    Individuals receiving the information must exercise their independent judgment in determining its appropriateness for a particular purpose.

    GLOBAL PHARMA MAKES NO REPRESENTATIONS OR WARRANTIES, EITHER EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY WARRANTIES OR MERCHANTABILITY, FITNESS FOR A PARTICULER PURPOSE WITH RESPECT TO THE INFORMATION SET FORTH HEREIN OR THE PRODUCT WHICH THE INFORMATION REEFERS. GLOBAL PHARMA WILL NOT BE RESPONSIBLE FOR DAMAGES RESULTING FROM USE OF RELIANCE UPON THIS INFORMATION.

WhatsApp
+91 9819994077